sP-selectin is a useful biomarker for cardiovascular risk: findings from an elderly primary healthcare population

Conclusion: sP-selectin is a prognostic biomarker for mortality in an elderly primary healthcare population. Compared with NT-proBNP, sP-selectin is at least as effective. We therefore suggest sP-selectin as an additional biomarker to be used in assessing the elderly to identify those at risk of cardiovascular events. The results presented should be considered hypothesis-generating, and warrant more research.
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Original articles Source Type: research